Search

Your search keyword '"Radovanovic, Dejan"' showing total 21 results
Start Over Author "Radovanovic, Dejan" Publisher european respiratory society
21 results on '"Radovanovic, Dejan"'

1. The Successful Procedures Of weaning from Tracheostomy (SPOT) study: preliminary analysis of predictive factors for failure and validation of the QsQ score

Author

Radovanovic, Dejan, primary, Gatti, Marina, additional, Spitaleri, Debora, additional, Pini, Stefano, additional, Saad, Marina, additional, Gramegna, Andrea, additional, Mondoni, Michele, additional, Aliberti, Stefano, additional, Di Marco, Fabiano, additional, Centanni, Stefano, additional, Blasi, Francesco, additional, and Santus, Pierachille, additional

Published
2023
Full Text
View/download PDF

15. Respiratory viruses in stable state bronchiectasis

Author

Gramegna, Andrea, primary, Aliberti, Stefano, additional, Zucchetti, Stefano, additional, Simonetta, Edoardo, additional, Castelli, Daniele, additional, Cavallero, Annalisa, additional, Conio, Valentina, additional, Grosso, Amelia, additional, Faverio, Paola, additional, Radovanovic, Dejan, additional, Terraneo, Silvia, additional, Di Marco, Fabiano, additional, Pesci, Alberto, additional, Airoldi, Cristina, additional, Valenti, Vincenzo, additional, Corsico, Angelo, additional, Santus, Pierachille, additional, Centanni, Stefano, additional, and Blasi, Francesco, additional

Published
2019
Full Text
View/download PDF

20. Lung pathophysiology in patients with long COVID-19: one size definitely does not fit all.

Author

Radovanovic D and D'Angelo E

Abstract

Despite reduced resting lung volumes and D LCO , patients with long COVID and dyspnoea have similar physiological response to exercise to healthy subjects. D LCO impairment can marginally explain heterogeneity of complex syndromes such as long COVID. https://bit.ly/40j4aX6., Competing Interests: Conflict of interest: The authors have nothing to disclose., (Copyright ©The authors 2023.)

Published
2023
Full Text
View/download PDF

21. Helmet CPAP treatment in patients with COVID-19 pneumonia: a multicentre cohort study.

Author

Aliberti S, Radovanovic D, Billi F, Sotgiu G, Costanzo M, Pilocane T, Saderi L, Gramegna A, Rovellini A, Perotto L, Monzani V, Santus P, and Blasi F

Subjects
Betacoronavirus, COVID-19, Equipment Design, Female, Humans, Infection Control instrumentation, Infection Control methods, Italy, Male, Middle Aged, Outcome and Process Assessment, Health Care, Oximetry methods, Quality Improvement, Respiratory Function Tests methods, SARS-CoV-2, Continuous Positive Airway Pressure instrumentation, Continuous Positive Airway Pressure methods, Continuous Positive Airway Pressure standards, Coronavirus Infections epidemiology, Coronavirus Infections physiopathology, Coronavirus Infections therapy, Head Protective Devices, Hypoxia etiology, Hypoxia therapy, Pandemics, Pneumonia, Viral blood, Pneumonia, Viral epidemiology, Pneumonia, Viral etiology, Pneumonia, Viral physiopathology, Pneumonia, Viral therapy
Abstract

Competing Interests: Conflict of interest: S. Aliberti reports grants and personal fees from Bayer Healthcare, Aradigm Corporation, Grifols, Chiesi and INSMED, personal fees from AstraZeneca, Basilea, Zambon, Novartis, Raptor, Actavis UK Ltd and Horizon, outside the submitted work. Conflict of interest: D. Radovanovic has nothing to disclose. Conflict of interest: F. Billi has nothing to disclose. Conflict of interest: G. Sotgiu has nothing to disclose. Conflict of interest: M. Costanzo has nothing to disclose. Conflict of interest: T. Pilocane has nothing to disclose. Conflict of interest: L. Saderi has nothing to disclose. Conflict of interest: A. Gramegna has nothing to disclose. Conflict of interest: A. Rovellini has nothing to disclose. Conflict of interest: L. Perotto has nothing to disclose. Conflict of interest: V. Monzani has nothing to disclose. Conflict of interest: P. Santus has nothing to disclose. Conflict of interest: F. Blasi reports grants and personal fees from AstraZeneca, Chiesi, GSK, Insmed and Pfizer, grants from Bayer, personal fees from Guidotti, Grifols, Menarini, Mundipharma, Novartis, Zambon and Vertex, outside the submitted work.

Published
2020
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results